Gene function identified in type 1 diabetes progression

July 23, 2014 by Kerry Faulkner
The pancreas: type 1 diabetes is caused when the pancreas fails to produce enough insulin because the necessary beta-cells have been destroyed by the body’s immune system. Credit: Rafael Mondini

IDENTIFYING a genetic weakness that causes type 1 diabetes in children has opened the way for development of a treatment capable of preventing the disease.

The genetic weakness has been pinpointed by researchers at Perth's Harry Perkins Institute of Medical Research working as part of a global consortium, who studied the mechanisms for the gene cathepsin H (CTSH) to influence in the pancreas of type 1 diabetics.

Type 1 diabetes is caused when the pancreas fails to produce enough insulin because the necessary beta-cells have been destroyed by the body's immune system.

The research shows CTSH may affect disease progression by modulating the survival and function of which are the target of autoimmune assault.

However, the exact way CTSH works in beta-cells has not been determined— of CTSH has been found to be beneficial but a weakness in the CTSH gene can make cells more vulnerable to an .

The Institute's Grant Morahan says the research investigated over 200 blood samples at the gene's RNA and protein levels from patients worldwide, to see how changed.

"Our results showed the CTSH gene was active but we had to go to the next step and show that RNA was translated into protein—that was really dotting the 'I's and crossing the 'T's," Prof Morahan says.

"Type 1 diabetes is due to the insulin producing beta-cells being destroyed by an autoimmune response and this particular variant in the CTSH gene makes those cells more vulnerable to attack from the immune system.

"This is crucial, because now we know the exact molecular weakness in beta cells."

CTSH gene presence also protects beta-cells

The WA team's Danish collaborators showed higher levels of the CTSH gene protected the body's antibody-producing beta-cells from dying when attacked by the immune system. Those people with higher levels had better cell function and slower progression to .

Professor Morahan says proving this protective capability means it is possible to develop drugs either to increase production of the gene in beta-cells, or to mimic the function of CTSH in beta cells and prevent the disease.

"We should now try and find some way of blocking the biochemical pathway to cell death that the CTSH molecule participates in, so that's what people will be looking at in the next stage," he says.

"Type 1 diabetes affects children and they have it for the rest of their lives so the goal of our research is to come up with a way to prevent children from getting ."

Explore further: Connexins: Providing protection to cells destroyed in Type 1 diabetes

More information: "CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients." Tina Fløyel, et al. PNAS DOI: 10.1073/pnas.1402571111

Related Stories

Connexins: Providing protection to cells destroyed in Type 1 diabetes

November 7, 2011
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone ...

Diabetes susceptibility gene regulates health of cell's powerhouse

June 19, 2014
A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania found that a susceptibility gene for type 1 diabetes regulates self-destruction of the cell's energy factory. They report their ...

Loss of function of a single gene linked to diabetes in mice

January 4, 2014
Researchers from the University of Illinois at Chicago College of Medicine have found that dysfunction in a single gene in mice causes fasting hyperglycemia, one of the major symptoms of type 2 diabetes. Their findings were ...

Researchers find new pathway connected to type 2 diabetes

March 19, 2014
Scientists at the Children's Hospital of Eastern Ontario (CHEO) Research Institute have discovered a cellular pathway that is responsible for keeping blood sugar levels low in obese or pre-diabetic people, and may prevent ...

Targeting a cell cycle inhibitor promotes beta cell replication

January 16, 2014
Researchers replicated human pancreatic beta cells—which produce insulin—in a mouse model in which donor cells were transplanted. The newly replicated cells retained features of mature beta cells and showed a physiological ...

Study shows new imaging technique can track beta cell status

June 12, 2014
In a recent Diabetes publication, researchers used a radiotracer or marker and PET scanning as a non-invasive technique to follow changes in how many active beta cells a person has.

Recommended for you

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.